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Abstract  7 
Objective: to compare the effectiveness and harms of higher exercise dose, including higher 8 
exercise load and/or higher volume, with lower exercise dose (lower load and/or lower 9 
volume) in people with rotator cuff tendinopathy 10 
Design: Systematic review (PROSPERO: CRD42017077478) 11 
Data sources: CENTRAL, MEDLINE, EMBASE, CINAHL from inception to March 2019. 12 
Study selection: Randomised controlled trials comparing higher versus lower dose exercise 13 
that investigated function and pain (overall, activity, night) and adverse event outcomes were 14 
independently determined by two reviewers. 15 
Data extraction and risk of bias: Two authors independently extracted data and assessed 16 
risk of bias using the Cochrane tool. The primary endpoint was >six weeks to three months 17 
(other endpoints included up to six weeks & beyond three months) and GRADE was used to 18 
assess evidence certainty.  19 
Data synthesis: Three trials (N=283), none at low risk of bias for all domains, were included. 20 
Low certainty evidence (1 trial, N=102) indicated improved function (20 points [95% CI 12 21 
to 28 points] on 0-100 point scale) with higher load and volume exercise at three months, but 22 
little or no clinically important between-group difference in activity or night pain (overall 23 
pain not reported). Very low certainty evidence (1 trial, N=120) indicated higher load 24 
exercise conferred no function benefits over lower load exercise at six weeks. Very low 25 
certainty evidence (1 trial, N=61) indicated benefit of uncertain clinical importance in 26 
function with higher versus lower volume exercise at three months and clinically important 27 
benefit at >3 months (pain outcomes not reported). Risk of adverse events was uncertain. 28 
Conclusions: There are few studies that investigate higher dose exercise for rotator cuff 29 
tendinopathy. There was low to very low certainty and conflicting evidence about the value 30 
of higher exercise dose in people with rotator cuff tendinopathy. 31 
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 33 
Introduction 34 
Shoulder pain is estimated to have a prevalence between 15 to 30% in the general population, 35 
with prevalence increasing with age [1]. Rotator cuff tendinopathy is the most common 36 
cause, accounting for up to 80% of all cases of shoulder pain in primary care [2]. While often 37 
self-limiting, up to 50% of patients who present for care may continue to experience ongoing 38 
pain and disability beyond 12 months [2]. This results in significant morbidity and health 39 
resource utilisation given shoulder function is essential to personal hygiene, dressing and 40 
work [2].  41 
 42 
Clinical guidelines recommend clinician-prescribed exercise for rotator cuff tendinopathy[3, 43 
4]. However, there are conflicting data about its benefits [5-7]. An updated Cochrane review 44 
synthesised exercise and manual therapy evidence for rotator cuff tendinopathy from 60 trials 45 
(3,620 participants) up until 2015. The authors reported high quality evidence from a single 46 
trial (120 participants) [8] indicating that manual therapy and exercise provided no patient-47 
reported benefits in pain and function outcomes over placebo at 22 weeks follow-up. 48 
However, the exercise component was not loaded progressively so could be defined as lower 49 
load [6]. This lack of benefit in pain and function outcomes was supported by very low 50 
quality evidence from two trials (89 participants) that compared manual therapy and exercise 51 
to no treatment although only one trial progressed exercise load in the active group [9, 10]. 52 
By contrast low quality evidence from one trial of exercise versus placebo (80 participants in 53 
these treatment groups) that did progress load in the exercise group reported pain and 54 
function outcome benefit favouring the exercise group for overall pain and function but not 55 




While the overall body of evidence indicates a lack of consensus regarding the benefit of 58 
exercise for rotator cuff tendinopathy, previous systematic reviews have not generally 59 
considered whether exercise dose parameters such as load progression and repetitions 60 
influence outcomes. Higher load may be more beneficial for neuromuscular adaptation and 61 
higher volume might develop greater muscular endurance [12, 13]. Greater neuromuscular 62 
adaptation and muscular endurance could improve function and improve shoulder symptoms 63 
[14]. In a systematic review of prescription parameters reported in randomised controlled 64 
trials (RCTs) of exercise interventions for rotator cuff tendinopathy, trials that progressively 65 
loaded exercise were more likely to report improvements in shoulder function compared with 66 
trials where exercise was not progressively loaded [15]. However, it is unclear if these 67 
improvements are clinically important or if these findings are robust in view of potential 68 
biases in the included studies. Further exploration of the relationship between exercise dose 69 
and outcomes in rotator cuff tendinopathy therefore appears warranted.  70 
 71 
The aim of this systematic review was to compare the effectiveness and harms of higher 72 
exercise dose, including higher exercise load and/or higher volume, with lower exercise dose 73 
(lower load and/or lower volume) in people with rotator cuff tendinopathy. 74 
 75 
Methods 76 
Criteria for considering studies for this review 77 
We adopted similar methods to the updated Cochrane review of manual therapy and exercise 78 
interventions for rotator cuff tendinopathy [6]. Our review was conducted in accordance with 79 
the PRISMA statement guidelines (Preferred Reporting Items for Systematic reviews and 80 
Meta-Analyses) [16] and was registered with the International Prospective Register of 81 




Types of studies 84 
We included RCTs of any design (e.g. parallel, factorial, cross-over) and controlled trials 85 
using a quasi-randomised method of allocation. There were no restrictions based on 86 
language. 87 
 88 
Types of participants  89 
We included trials that recruited participants aged 16 years and over with a primary 90 
complaint (any duration) of shoulder pain (with or without referral into the arm) labelled 91 
and/or diagnosed as rotator cuff tendinopathy by any means. Rotator cuff tendinopathy has 92 
many synonyms in the literature including rotator cuff disease, rotator cuff related pain, 93 
subacromial impingement syndrome, rotator cuff tendinitis, supraspinatus, infraspinatus or 94 
subscapularis tendonitis or tendinopathy, subacromial bursitis and rotator cuff tears. Trials 95 
using these synonyms were included as were trials where participants had unspecified 96 
shoulder pain provided that the inclusion/exclusion criteria were compatible with a diagnosis 97 
of rotator cuff disease (i.e. anterolateral shoulder pain that is made worse by active and 98 
resisted shoulder elevation and associated with preserved passive range of motion [4]). We 99 
included trials with participants with multiple shoulder disorders, if data were presented 100 
separately for our population of interest. 101 
 102 
Trials were excluded if they included participants with a full thickness tear involving more 103 
than one rotator cuff tendon (based on presentation or imaging findings), gross shoulder 104 
instability, significant shoulder trauma, previous shoulder surgery, shoulder osteoarthritis, 105 
patients with hemiplegia affecting the shoulder, a complex myofascial neck/shoulder/arm 106 
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pain condition, suspected cervical spine referred pain, or a systemic inflammatory condition 107 
(e.g. rheumatoid arthritis).  108 
 109 
Types of interventions 110 
We included trials that utilised exercise designed to load the shoulder joint, this could include 111 
any active movement in any shoulder plane. Passive movements and pendular movements 112 
(also classified as passive [e.g. [17]]) were excluded. Trials were included if they compared 113 
higher versus lower dose exercise as defined in the trials. Higher dose could include heavier 114 
load (using external weight or resistance) or greater volume (repetitions x sets x frequency). 115 
The volume was defined as a total of all sessions they performed, including supervised and/or 116 
home-based exercise. There was no minimum dose (volume or load) because diverse exercise 117 
interventions can lead to neuromuscular adaptations [12, 13]. Trials needed to explicitly state 118 
the load or volume, or both, in each group so there was certainty that these dose parameters 119 
varied. The comparator group needed to be the same setting (e.g. home-based, supervised, or 120 
a combination) and type of exercise (e.g. isometric, isotonic, eccentric) so dose was the 121 
primary variable being investigated. Trials that also progressed other exercise parameters 122 
such as the range of motion or the type of exercise (static to dynamic) were included if these 123 
were identical in both treatment groups. Co-interventions, including mobilisation, 124 
manipulation and massage modalities, glucocorticoid injections and analgesia were allowed 125 
even if they were not applied equally to groups. 126 
 127 
Types of outcome measures 128 
For effectiveness we included patient-reported shoulder function, and the following pain 129 
outcomes (as per the Page et al review [6]): overall shoulder pain, activity and night pain in 130 
the shoulder. When data for more than one function scale was reported within a trial, we 131 
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extracted data from the function scale highest on the shoulder function scale hierarchy 132 
reported by Page et al [6]:  133 
 Shoulder Pain and Disability Index (SPADI) [18]. Scored on a 0 to 100-point scale, 134 
where 0 best; 135 
 Croft Shoulder Disability Questionnaire [19] Scored on a 0 to 22-point scale, where 0 136 
is best; 137 
 Constant-Murley Score [20] Scored on a 0 to 100-point scale, where 100 is best; 138 
 any other shoulder-specific function scale. 139 
 140 
Overall pain, pain with activity and night pain could be measured on a visual analogue scale 141 
(VAS), numerical or categorical rating scale. For harms we included the proportion of 142 
participants experiencing adverse events. 143 
 144 
Outcome times were selected to identify short (up to 6 weeks), medium (>six and up to three 145 
months) and longer-term (>three months) effects of the exercise interventions. The longest 146 
timepoint was extracted where multiple timepoints were reported within a given range. We 147 
chose >six weeks and up to three months as the primary endpoint given this is enough time 148 
for exercise to lead to greater muscle volume and strength, and potentially, better function 149 
[12]. 150 
 151 
Data sources and search 152 
Relevant trials published up to March 2015 were identified from the updated Cochrane 153 
review of manual therapy exercise interventions for rotator cuff tendinopathy [6]. Given we 154 
focused on exercise for rotator cuff tendinopathy, the search strategy from the Page et al. [6] 155 
was modified to exclude terms related to adhesive capsulitis as well as non-exercise 156 
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interventions. For more recent papers we repeated the search in the Cochrane Central 157 
Register of Controlled Trials (CENTRAL; The Cochrane Library March 2019, Issue 3), Ovid 158 
MEDLINE (March 2015 to March 2019), Ovid EMBASE (March 2015 to March 2019), and 159 
CINAHL Plus (EBSCO, March 2015 to March 2019).  160 
 161 
The updated search strategies for all databases are shown in Supplementary appendix 1. We 162 
also searched gray literature via OpenGray and ongoing trials via the National Institute of 163 
Health (clinicaltrials.gov) and the World Health Organisation (http://www.who.int/ictrp) 164 
International Clinical Trials Registries, using the terms ‘rotator cuff disease’ [condition] and 165 
‘exercise’ [intervention] up to March 2019.  166 
 167 
Selection of studies 168 
Two authors (PM, GS) independently screened titles and abstracts for potentially eligible 169 
trials, based on a predetermined checklist of inclusion criteria. The full text of potentially 170 
eligible trials was retrieved and independently assessed by the same two authors to determine 171 
eligibility. Any discrepancies were resolved via discussion, or by consulting a third author 172 
where necessary (CL).  173 
 174 
Data extraction 175 
Two authors (PM, GS) independently extracted data onto a standard data extraction form. 176 
Discrepancies were resolved through discussion until consensus was reached, otherwise a 177 
third author (RB) was consulted to adjudicate.  178 
 179 
The following data were extracted from each study: 180 
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• Trial characteristics (sample size, first author name, year of publication, type of trial 181 
[e.g. parallel, crossover], country, source of funding, trial registration status 182 
[registration number if reported]).  183 
• Participant characteristics (inclusion and exclusion criteria, age, gender, duration of 184 
symptoms,).  185 
• Intervention including exercise characteristics (exercises performed, sets, repetitions, 186 
frequency, duration, how exercise was loaded, how exercise was progressed and how 187 
often, adherence measures, advice about pain during exercise)  188 
• Comparator intervention exercise characteristics 189 
• Co-interventions in each group, if any 190 
• Outcomes reported, including the measurement instrument used and timing of 191 
outcome assessment. 192 
 193 
To minimise potential bias, we used the following a priori decision rules for selecting 194 
outcome data: 195 
 Preference was given to data that were adjusted for baseline values (e.g. ANCOVA) if 196 
available and intention-to-treat. 197 
 Where follow-up and change scores were reported for the same outcome, we planned 198 
to extract follow up scores. 199 
 For cross-over RCTs, we planned to only extract data for the first period. 200 
 201 
Risk of bias assessment  202 
Risk of bias for each study was performed using the Cochrane Collaboration’s tool for 203 
assessing risk of bias, described fully in the Cochrane Handbook for Systematic Reviews of 204 
Interventions [21]. Risk of bias was performed independently by two of three authors (PM, 205 
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GS or RJ) and discrepancies were resolved through discussion until consensus was reached, 206 
otherwise a third author (RB) was consulted to adjudicate.  207 
 208 
The following domains were rated as high risk of bias if they were not performed adequately, 209 
unclear risk of bias if it was not clearly reported or low risk of bias if performed adequately: 210 
random sequence generation, allocation concealment, blinding of participants and personnel, 211 
blinding of outcome assessment, incomplete outcome data, outcome reporting bias, and other 212 
sources of bias (i.e. baseline imbalance, unequal application of co-interventions across 213 
treatment groups). All domains had to achieve a low risk of bias rating for the study to be 214 
classified as being at low overall risk of bias. 215 
 216 
Measures of treatment effect 217 
Review Manager (RevMan) 5.3 was used to calculate measures of treatment effect. Adverse 218 
events were expressed as relative risk (RR) and 95% confidence intervals. Mean pain was 219 
expressed as mean difference (MD) and 95% confidence intervals on a 0 to 100-point VAS 220 
scale, with a higher score indicating more pain. Mean function was also expressed as MD and 221 
95% confidence intervals with a lower score indicating less disability or better function. So 222 
that zero was best function in all scales, we reversed scores for scales such as the Constant-223 
Murley score and Shoulder Rating Questionnaire (SRQ) where a higher score indicates less 224 
disability or better function. For the SRQ we also transformed scores from a scale of 17 to 90 225 
to 0 to 100 scale [22]. We assumed a minimal clinically important difference of 10 on a 100-226 
point scale for function and 15 points on a 100-point scale for pain [6]. A clinically important 227 
difference was defined as a confidence interval where even the lower band (closest to null) 228 




Study authors were contacted (twice over four weeks) via email in any instances of missing 231 
data. If the data were not retrieved from the study authors, we planned to calculate standard 232 
deviation (SD) from the standard errors (SE), 95% CIs or P values, or use median and the 233 
Inter-quartile range (IQR) to approximate the mean and SD (SD=width of IQR/35), 234 
respectively. 235 
 236 
Data synthesis  237 
Meta-analysis was planned to pool results of trials with similar characteristics (e.g. 238 
participants, interventions, outcomes), however there was insufficient data to undertake data 239 
pooling. 240 
 241 
Summary of findings 242 
We created summary of findings tables [23] for a priori comparisons that included outcomes 243 
at the primary endpoint of >six weeks to three months. We rated the overall grading of the 244 
certainty of the evidence based on the GRADE approach (Grades of Recommendation, 245 
Assessment, Development and Evaluation Working Group) [24]. From an initial starting 246 
point of high certainty evidence, the level of evidence was downgraded (to moderate, low or 247 
very low) for each of the following: risk of bias, inconsistency of results, indirectness, 248 
imprecision, and publication bias.  249 
 250 
For dichotomous outcomes (e.g. adverse events), we planned to calculate absolute risk 251 
difference expressed as a percentage and relative percent change (the risk ratio – 1) expressed 252 
as a percentage. For continuous outcomes (e.g. function), we planned to calculate absolute 253 
change which is the difference in mean of higher and lower load groups at follow-up 254 
standardised to the original units and expressed as a percentage. The relative percent change 255 
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was also calculated as the mean difference between groups at follow-up divided by the mean 256 
of the lower load group at baseline, expressed as a percentage.  257 
 258 
Results 259 
Study selection 260 
Two eligible trials were identified from the Page et al. [6] systematic review [14, 25]. An 261 
additional 915 records (730 unique studies) were identified from the updated search 262 
conducted from 2015 to 9 March 2019. Of these, we assessed 12 in full text and identified 263 
one additional trial for inclusion [26] (Figure 1). Two trials were registered in trial registries 264 
[14, 26], (Table 1) but none published their protocol.  265 
 266 
We excluded eleven trials after full text assessment for the following reasons: four compared 267 
different types of exercise as opposed to dose [27-30], one compared home versus group 268 
supervised group exercise [31], one compared pendular exercise with and without load [32], 269 
one compared painful vs painfree exercise [33], one compared home versus individual 270 
supervised exercise [34], one used the uninvolved asymptomatic shoulder as a control [35], 271 
one study compared the effect of the sequence in which exercises were performed [36] and 272 
one study included high dose exercise in both treatment arms (higher load and lower volume 273 
exercise versus lower load and higher volume exercise) [37], meaning it could not contribute 274 
to an understanding of the role of high versus low dose of exercise. 275 
 276 
Figure 1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2009 277 
flow diagram for literature search results. 278 
 279 
Trial, participant and intervention characteristics 280 
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The three included trials were all parallel group RCTs and included 283 participants [14, 25, 281 
26]. All trials had similar inclusion criteria (see Supplementary appendix 2). The trial, 282 
participant and intervention characteristics of the included trials are shown in table 1. Mean 283 
age varied between 46 and 55 years (slight male dominance) and symptom duration between 284 
three months and four years. Mean baseline function scores varied between 49 to 63 out of 285 
100 (lower score indicates better function).  286 
 287 
One trial compared 12 weeks of either higher load and higher volume exercise or lower load 288 
and lower volume exercise [14]; one trial compared higher versus lower load exercise over 289 
six weeks [26]; and one trial compared 12 weeks of either higher or lower volume exercise 290 
[25]. With regards to the comparators, two trials simply utilised active shoulder movements 291 
without additional load that can be considered subtherapeutic [14, 26]. In contrast, the 292 
comparator in Osteras et al [25] still contained progressive load exercise but of lower volume. 293 
No trials reported the actual load during exercise or exercise intensity. Exercise intensity (e.g. 294 
>70% 1 repetition maximum) was not reported in any trial [12]. Repetitions per week were 295 
higher in the ‘higher volume’ (2160 to 3150) compared with the ‘lower volume’ comparators 296 
(300 to 420) [14, 25]. 297 
 298 
One trial supervised all exercise sessions [25] while the other two trials included home 299 
exercise. Pain during exercise  was permitted in all intervention and comparator groups, aside 300 
from the Holmgren et al. [14] trial where this detail was not described for the comparator 301 
group. All trials included active non-weightbearing exercises in anatomical planes (e.g. 302 
flexion, abduction, external rotation). All trial participants received a glucocorticoid injection 303 
at baseline in one trial [14]. This trial also provided manual therapy ‘when necessary’ to 304 




All three trials assessed function with one trial measuring function using two instruments 307 
[14]. One trial used the SPADI [26], one used the Constant-Murley Score [14] and one used 308 
the SRQ [25]. Holmgren et al. [14] also used the Disability of the Arm and Shoulder Score 309 
(DASH) but we extracted data from the Constant-Murley Score. No trial reported overall 310 
pain, and Heron et al. [26] did not report pain at all. One trial reported activity pain [14] and 311 
one trial reported night pain [14]. Two trials also reported pain at rest (or inactivity) [14, 25] 312 
but as this was not a pre-specified outcome, we did not extract data for this outcome. Only 313 
two trials reported outcomes at our primary endpoint of >6 weeks to three months (both at 314 
three months) [14, 25]. Østeras et al. [25] also reported outcomes at nine and 15 months and 315 
data were extracted at 15 months for the >three months endpoint. Although Holmgren et al. 316 
[14] reported results at 12 months participants were offered surgery after the three-month 317 
assessment and data were reported sub-grouped by whether or not participants underwent 318 
surgery. Therefore the 12-month data were not extracted for this review. One trial only 319 
reported outcomes at 6 weeks [26].  320 
 321 
Table 1: Study, participant and exercise characteristics 322 
 323 
Risk of bias in included trials  324 
The risk of bias for each of the included trials is summarised in Figure 2. One trial was rated 325 
at low risk of bias for all domains other than performance bias, which was rated as uncertain 326 
[14]. Of note, this trial was rated at low risk of bias for all domains in the Page et al. 327 
Cochrane review [6]. While participants and the outcome assessor were blinded, the trial did 328 
not report whether the exercise explanations and verbal interaction (of potential effect and 329 
mechanisms) were identical between groups. Two of the remaining trials were susceptible to 330 
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performance [25, 26] and one trial was at risk of detection biases [25] due to lack of blinding 331 
of either participants or investigators; one trial was also at risk of attrition bias due to 332 
differences in the proportion of drop outs between groups [26]; and two trials were at risk of 333 
selective reporting [25, 26] because they reported one self-reported outcome measure and 334 
there were no associated trial protocols so it is unclear whether all outcomes were reported. 335 
 336 
Figure 2: Risk of bias summary: judgements about each risk of bias item for each 337 
included study. 338 
 339 
Comparison 1: higher load and higher volume versus lower load and lower volume 340 
There may be clinically important improvement in function with higher load and higher 341 
volume exercise at three months (Figures 3 & 4). Function was 47.5 points in the lower dose 342 
group and this improvement was 20 points better (95% CI 12 to 28) in the high dose group. 343 
There was little or no clinically important benefit of higher dose exercise for pain outcomes 344 
at > 6 weeks to three months. Activity pain was 41 points with low dose exercise and 16.0 345 
(95% CI 5.4 to 26.6) points better with high dose. Similarly, night pain was 27 points with 346 
low dose exercise and 12.0 points better (95% CI 2.1 to 21.9) with high dose. Overall pain 347 
and adverse events were not reported. This evidence arose from a single trial (97 participants 348 
for all reported outcomes) [14] and was low certainty (downgraded for bias and imprecision). 349 
 350 
Figure 3: Effects of higher load and higher volume versus lower load and lower volume 351 
exercise  352 
Figure 4: Summary of findings for the comparison of higher load and higher volume 353 




Comparison 2: higher load versus lower load  356 
Given outcomes were not reported at the primary endpoint for this comparison no summary 357 
of findings table was produced. There was no benefit with higher compared with lower load 358 
exercise for function at six weeks (Figure 5). Function was 42 points in the lower load group 359 
and this improvement was 5 points better in the higher load group (95% CI 15.9 better to 5.9 360 
worse). Overall, activity or night pain and adverse events outcomes were not reported. This 361 
evidence was from a single trial (61 participants for function outcome) and was low certainty 362 
(downgraded for risk of bias and imprecision due to the very short follow-up time). Note that 363 
only two (‘open chain’ and ‘range of movement’) of the three trial arms were eligible and 364 
included in this review. 365 
 366 
Figure 5: Effects of higher vs lower load exercise 367 
 368 
Comparison 3: higher volume versus lower volume 369 
There was benefit of uncertain clinical importance with higher volume exercise in function at 370 
three months (Figures 6 & 7). Function was 45.4 points in the lower volume group and 12.9 371 
points better (95% CI 7.6 to 18.1 points better) in the higher volume group. There was 372 
clinically important benefit at >three months; function was 43.1 points in the lower volume 373 
group and 17.8 points better in the higher volume group (95% CI 11.8 to 23.8 points better). 374 
Overall, activity or night pain were not reported. There was no reliable estimate of the 375 
adverse event rates. One participant in the higher volume group was reported to sustain a 376 
neck injury (no adverse events reported for the lower volume group). This evidence arose 377 
from one trial (56 participants for all reported outcomes) and was very low certainty 378 




Figure 6: Effects of higher vs lower volume exercise 381 




We found low to very low certainty and somewhat conflicting evidence about the value of 386 
higher exercise dose in people with rotator cuff tendinopathy. There was low certainty 387 
evidence from a single trial suggesting that higher load and higher volume exercise may 388 
result in a clinically important benefit in function but not activity or night pain at >six weeks 389 
to three months. There was also very low certainty evidence from another small single trial 390 
indicating that higher volume exercise might provide benefit of uncertain clinical importance 391 
for function at >six weeks to three months compared with lower volume exercise, although 392 
no data for pain were collected. Very low certainty evidence from one trial indicated that 393 
higher load exercise does not provide clinically important benefit over lower load exercise 394 
with respect to function up to six weeks. We are uncertain if there is an increased risk of 395 
adverse events with higher dose exercise, given the incomplete reporting of events and the 396 
low event rates. The evidence was downgraded for a variety of reasons including risk of 397 
performance and detection bias, imprecision and indirectness due to short follow-up times.  398 
 399 
The exercise programs examined in the three included trials generally reflected the 400 
interventions that are delivered in practice and in the rotator cuff tendinopathy literature [6]. 401 
Load was progressed when the exercise could be performed easily or with a defined pain 402 
response. None of the studies reported the specific intensity (e.g. repetition maximum) or 403 
absolute load. In contrast, trials that evaluated the effect of volume utilised fixed rather than 404 
progressive volumes and these were at least five times greater in the high volume (2160 to 405 
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3150 repetitions per week) versus the lower volume (300 to 420 repetitions per week) trial 406 
arms. Importantly, comparisons were unloaded active movements in two studies [14, 26] but 407 
still contained progressive load with lower volume [25] in one study. Given the poorly 408 
reported and heterogeneous interventions we cannot make any specific comments about the 409 
level of load (or intensity) and volume that may confer greater benefit. Final follow-up for 410 
the trial included in the higher load versus lower load exercise comparison was between four 411 
to six weeks which may not be enough time to demonstrate a beneficial effect of higher load 412 
exercise if one is present. Littlewood et al. [15] reported that maintenance of an exercise 413 
program for at least 12 weeks may be needed to demonstrate improvements in function.   414 
 415 
Adequate description of comparative load and volumes were part of our inclusion criteria. It 416 
was common across studies for other exercise parameters to be incompletely described, 417 
including pain during loading, exercise adherence, rest between exercise sets and exercise 418 
tempo (see Table 1). This limitation is important because clinicians are unable to implement 419 
incompletely described exercise interventions. Further, given adherence was poorly 420 
described, it is impossible to be certain of the dose in each comparator group, and therefore 421 
whether exercise dose or other mechanisms influenced outcome. For example, giving a 422 
patient permission to perform progressively loaded exercise, or do more exercise, may reduce 423 
fear, increase general shoulder use, and thereby improve outcome. Future exercise trials 424 
should consider reporting guidelines such as the Consensus on Exercise Reporting Template 425 
(CERT) [38] to ensure findings are translatable to practice.  426 
 427 
Comparison to the literature 428 
Littlewood et al (2015) reported superior function outcomes with resisted and greater volume 429 
(repetitions and sets) [15], but this was based on a narrative synthesis. Fourteen studies were 430 
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included in the Littlewood review, and only one of these studies specifically examined the 431 
effect of exercise dose and was also included in the current review [25]. Our systematic 432 
review investigated the effect of higher exercise dose (load and/or volume) on function and 433 
pain outcomes in rotator cuff tendinopathy. While our review suggested that higher load and 434 
higher volume exercise or higher volume exercise might confer superior functional outcomes 435 
compared to their lower dose comparisons, we did not find that higher load exercise was 436 
better than lower load exercise. However, if an exercise program needs to be maintained for 437 
at least 12 weeks before any benefit on function is evident as proposed by Littlewood et al. 438 
[15], this may explain the lack of observed benefit in the higher load versus lower load 439 
exercise comparison as exercise intervention and outcome reported extended only four to six 440 
weeks.   441 
 442 
A randomized trial by Ingwersen et al. [37] compared higher load but lower volume with 443 
lower load but higher volume exercise for rotator cuff tendinopathy. This study was not 444 
eligible for the current review but is worthy of discussion. The authors in this study equalized 445 
the work (volume multiplied by intensity) undertaken in each group. This is a worthwhile 446 
approach because it is able to identify whether load or volume is beneficial when accounting 447 
for overall work. In contrast, in the current review we were interested in whether additional 448 
load (and work) or additional volume (and work) or a combination of both were beneficial. 449 
The Ingwersen et al. [37] trial reported meaningful benefit in pain and function in both 450 
groups at 12 weeks with no between groups differences for higher intensity or higher volume 451 
exercise when work is equalized. This suggests that greater work may explain the between 452 
groups differences observed in studies in this review with higher load and volume or higher 453 




Strengths of the systematic review 456 
Our methods were based on a prior Cochrane review of exercise interventions for rotator cuff 457 
tendinopathy and adhered to best practice guidelines as outlined by the Cochrane 458 
collaboration and PRISMA to minimise potential sources of bias. Inclusion and exclusion 459 
criteria were determined a priori and were clearly defined to minimise selection bias.  460 
 461 
Limitations 462 
The main limitation is that only three trials met our inclusion criteria. We performed a 463 
comprehensive search and did not find any ongoing trials in trial registries, so publication 464 
bias is not likely. A further substantial limitation is diversity between exercise interventions. 465 
Comparators in two of the three trials were unloaded and could be considered subtherapeutic 466 
[14, 26], while the third trial included substantial progressive load in the higher load arm 467 
[25]. This, coupled with the sparse literature, makes it impossible to provide guidance about 468 
specific levels of load (or intensity) or volume that may be beneficial for individuals. A 469 
potential limitation among the included trials that may influence interpretation is 470 
contamination (e.g. lower does groups receiving higher dose or vice versa) between exercise 471 
interventions. 472 
 473 
Future research 474 
Only three studies that meet our selection criteria were identified. High quality adequately 475 
powered randomised trials are needed to investigate the value of exercise for rotator cuff 476 
tendinopathy. Future research should seek to determine optimal dose parameters for 477 
improvement in pain and function outcomes among people with rotator cuff tendinopathy. 478 
Future trialists should consider using function as the primary outcome given that the higher 479 
dose interventions in this review seemed to confer less differential benefit between exercise 480 
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interventions. These trials should adequately describe exercise interventions according to 481 
published guidelines such as the CERT [38] Checklist [39]. Robust monitoring of exercise 482 
fidelity (e.g. appropriately implementing progressive load) and adherence is also required in 483 
order to draw valid conclusions about the effect of dose on outcomes.  484 
 485 
Implications for practice 486 
Despite conflicting data, clinical guidelines continue to recommend clinician-prescribed 487 
exercise for rotator cuff tendinopathy. Based upon the currently available low to very low 488 
certainty evidence, exercise that progressively increases load and utilises greater volume may 489 
confer superior function outcomes compared with lower dose exercise regimens, although the 490 
certainty of these findings need to be confirmed in high quality trials. Clinicians should 491 
explain to patients that it is unclear whether exercise improves pain, while exercise may need 492 
to be maintained for at least 12 weeks before benefits in function become evident. 493 
 494 
Conclusions:  495 
There are few studies that investigate higher dose exercise for rotator cuff tendinopathy. 496 
There was low to very low certainty and conflicting evidence about the value of higher 497 
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